GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hamilton Thorne Ltd (TSX:HTL) » Definitions » 3-Year EPS without NRI Growth Rate

Hamilton Thorne (TSX:HTL) 3-Year EPS without NRI Growth Rate : 0.00% (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Hamilton Thorne 3-Year EPS without NRI Growth Rate?

Hamilton Thorne's EPS without NRI for the three months ended in Mar. 2024 was C$-0.01.

During the past 12 months, Hamilton Thorne's average EPS without NRI Growth Rate was -866.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Hamilton Thorne was 141.00% per year. The lowest was -37.00% per year. And the median was 6.70% per year.


Competitive Comparison of Hamilton Thorne's 3-Year EPS without NRI Growth Rate

For the Medical Devices subindustry, Hamilton Thorne's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hamilton Thorne's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hamilton Thorne's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Hamilton Thorne's 3-Year EPS without NRI Growth Rate falls into.



Hamilton Thorne 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Hamilton Thorne  (TSX:HTL) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Hamilton Thorne 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Hamilton Thorne's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Hamilton Thorne (TSX:HTL) Business Description

Traded in Other Exchanges
Address
100 Cummings Center, Suite 465E, Beverly, MA, USA, 01915
Hamilton Thorne Ltd is engaged in providing precision instruments, consumables, software, and services that reduce cost, increase productivity, improve results, and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. The company markets its products and services under the Hamilton Thorne, Gynemed, and Embryotech Laboratories brands, through its growing sales force and distributors. The company's customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments. It has a single reporting segment being Engaged in Sales to the ART, Research, and Cell Biology Markets.
Executives
Robert J Potter Director

Hamilton Thorne (TSX:HTL) Headlines

No Headlines